Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Total Non-Current Liabilities (2018 - 2025)

Veracyte's Total Non-Current Liabilities history spans 10 years, with the latest figure at $96.2 million for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities fell 22.12% year-over-year to $96.2 million; the TTM value through Dec 2025 reached $96.2 million, down 22.12%, while the annual FY2025 figure was $96.2 million, 22.12% down from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $96.2 million at Veracyte, down from $110.1 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $123.5 million in Q4 2024 and bottomed at $49.1 million in Q1 2021.
  • The 5-year median for Total Non-Current Liabilities is $79.8 million (2022), against an average of $85.3 million.
  • The largest annual shift saw Total Non-Current Liabilities surged 217.27% in 2021 before it decreased 22.12% in 2025.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $89.9 million in 2021, then dropped by 12.44% to $78.7 million in 2022, then decreased by 11.06% to $70.0 million in 2023, then soared by 76.39% to $123.5 million in 2024, then dropped by 22.12% to $96.2 million in 2025.
  • Per Business Quant, the three most recent readings for VCYT's Total Non-Current Liabilities are $96.2 million (Q4 2025), $110.1 million (Q3 2025), and $122.5 million (Q2 2025).